High-yield points
- Pilocytic spinal astrocytomas: these children survive, but most progress. Plan for repeated interventions and decades of follow-up .
- Resect only where a plane exists, and stop on a significant D-wave drop. Pre-existing deficits rarely recover, so operate before they appear .
- Ask for full molecular profiling, including RNA fusion panels and methylation. A targetable driver is the rule .
- Infiltrative tumors: an H3 K27M-mutant spinal diffuse glioma is grade 4 regardless of histology .
- Spinal glioblastoma: survival is about a year. Radiotherapy is the one treatment with consistent benefit .
- Prevent and track deformity: consider laminoplasty, and follow children with scoliosis films after any multilevel laminectomy, especially at the thoracolumbar junction or under 13 .
Intramedullary spinal cord tumors (IMSCTs) make up 1–10% of childhood CNS tumors. Astrocytomas are the commonest subtype in young children, and most are low grade, usually pilocytic . The working rules:
- Low-grade gliomas (LGG): children almost always survive, but progression and long-term sequelae are the rule. Maximal safe resection, guided by neuromonitoring, is the backbone .
- High-grade gliomas (HGG): rare and dismal. The H3 K27M-mutant diffuse midline glioma is CNS WHO grade 4 wherever it arises .
- Spinal deformity after multilevel surgery is common and must be watched for years .
Epidemiology and presentation
- Histology mix varies with age.
- Population data (≤21 years): astrocytomas are the commonest subtype in a SEER analysis of childhood IMSCTs .
- NCDB, ages 0–21 (1,066 patients):
- Histology: ependymoma 57.5%, astrocytoma 36.1%, hemangioblastoma 6.4%;
- Survival: astrocytoma carried worse overall survival (HR 2.21) .
- The older the cohort, the more ependymomas it contains.
- Spinal cord LGG in young children (Toronto, 29 patients):
- Frequency: 4.6% of all pediatric LGGs.
- Who: an age peak at 2 years and a male predominance.
- Histology: 86% were grade 1 astrocytomas .
- Location: in a meta-analysis of 578 pediatric spinal astrocytomas, 53.8% were cervical and 40.8% thoracic .
- Symptoms are slow and easily missed:
- back or neck pain;
- gait change, or regression in walking;
- torticollis;
- progressive scoliosis.
- Why it matters: patients with no or mild deficits before surgery were rarely made worse by it, so early diagnosis protects function .
Imaging: astrocytoma vs. ependymoma
- MRI of the whole neuraxis with gadolinium. Dissemination changes management and prognosis .
- Features favoring ependymoma in a 43-patient comparison :
- central location;
- enhancement, which is diffuse;
- hemorrhage and the hemosiderin "cap sign";
- syringohydromyelia, the only independent discriminator (OR 62.9).
- Astrocytoma: eccentric, infiltrative, poorly marginated, often with an intratumoral cyst. There is usually no surgical plane .
Molecular pathology
- Spinal LGGs are MAPK-driven, like intracranial pediatric LGG.
- German HIT-LGG/SIOP-LGG cohort (128 patients; 76% pilocytic) :
- KIAA1549-BRAF fusion: 40% (14/35);
- FGFR1-TACC1 fusion: 12% (3/26);
- BRAF V600E: only 3% (2/66).
- Colorado/SickKids cohort: KIAA1549-BRAF in 42% (13/31). Every fusion-positive patient survived the study period .
- Comprehensive profiling pays (26 children) :
- Driver alteration found in 92%, but only a third were detectable with standard diagnostic tests.
- Druggable: 23 of 24 drivers were potentially targetable.
- Methylation profiling reclassified tumors: 55% clustered with pilocytic astrocytoma, and the rest included:
- diffuse leptomeningeal glioneuronal tumor (3 cases);
- high-grade astrocytoma with piloid features (1);
- pleomorphic xanthoastrocytoma (1).
- High grade: H3 K27M-mutant spinal diffuse glioma (77 cases) :
- Grade: all CNS WHO grade 4.
- Who: median age 35, so these are mostly young adults.
- Prognosis: better than H3 K27M-mutant brain tumors.
- Genetics: TP53 mutation in 58.8%, mutually exclusive with PPM1D and NF1 mutations. TP53-mutant cases leaned pediatric.
- Worse outcome with: glioblastoma histology, Ki-67 >10%, and CDK6 or RB-pathway alterations.
- WHO 2021:
- "Diffuse midline glioma, H3 K27-altered" is a pediatric-type diffuse high-grade glioma.
- Grading is within tumor type, with Arabic numerals .
Surgery
- Goal: radical resection only where a plane exists. In Constantini's 164 patients aged ≤21 :
- Extent: GTR (>95%) in 76.8%, subtotal (80–95%) in 20.1%;
- Histology: 79.3% low grade;
- Safety: no operative deaths;
- Function at 3 months: 60.4% unchanged, 15.8% better, 23.8% worse;
- 5-year PFS: 78% for LGG vs. 30% for HGG;
- Resection <80% did significantly worse.
- Extent of resection in LGG:
- Toronto: 5-year PFS was 88% after GTR vs. 34% after all other therapy. Every patient was alive at a median of 8.2 years .
- Population data (SEER, 348 patients): both GTR (HR 0.39) and partial resection (HR 0.37) were associated with better survival than biopsy .
- Meta-analysis: GTR may give better 5-year overall survival than subtotal resection .
- Intraoperative neuromonitoring:
- Modalities: somatosensory evoked potentials (SSEPs), muscle motor evoked potentials (MEPs) and the epidural D-wave.
- What changes surgery: in Sala's historical-control study, a D-wave drop of more than 50% was the main reason to stop resecting.
- What it bought: monitored patients had significantly better McCormick grades at follow-up .
- Transient deficits are expected and are predicted by the end-of-case neurophysiology .
- HGG: weigh resection against function. In 35 malignant spinal astrocytomas (ages 2–61) :
- Anaplastic astrocytoma (AA): median OS 72 months. Radical resection gave 78% 4-year survival vs. 38% after subtotal resection, a trend after correction for multiple comparisons.
- Glioblastoma: median OS 9 months and 0% at 5 years, no better than biopsy plus radiotherapy historically.
- Function: 40% declined neurologically.
- Dissemination along the neuraxis shortened survival.
- Infiltrative diffuse spinal gliomas (22 patients; median age 23.6) :
- Survival: median 397 days.
- Better survival with: GTR and chemotherapy.
- Not prognostic here: K27M status.
Adjuvant therapy
- LGG: surveillance, re-resection, chemotherapy, then targeted drugs.
- German cohort :
- Survival: 10-year OS 93%, but 10-year EFS only 38%.
- Progression: 73/128 progressed, some up to six times.
- Retreatment: 36 needed repeat resection and 47 needed nonsurgical treatment.
- Risk factors: dissemination worsened outcome; age ≥11 years and total resection favored EFS.
- Chemotherapy (systematic review, 98 children, mostly platinum-based) :
- Response: complete 9%, incomplete 9%, stable disease 42%;
- Progression: 26%.
- MEK and NTRK inhibitors: 3 of 4 profiled patients improved on trametinib or larotrectinib, and 2 had partial responses .
- Radiotherapy: in SEER, radiation was associated with worse survival (HR 3.74). This likely reflects confounding by higher-risk disease . Most teams reserve it for refractory LGG.
- HGG: radiotherapy plus chemotherapy. In pooled pediatric spinal glioblastoma cases (81 patients; mean age 10.7) :
- Survival: mean PFS 10.95 months; mean OS 13.4 months.
- Radiotherapy improved PFS: 15.2 vs. 2.1 months.
- Both radiotherapy and chemotherapy were protective for OS.
- Worse with: age over 7 years and cervical location.
Spinal deformity and late effects
- Laminectomy and deformity (Johns Hopkins, 161 children) :
- Incidence: progressive deformity needing fusion developed in 27%, at a median of 9 years.
- Independent risk factors:
- age <13 years (OR 4.4);
- preoperative scoliosis, Cobb >10° (OR 3.2);
- surgery spanning the thoracolumbar junction (OR 2.6);
- tumor-associated syrinx (OR 3.4);
- each additional resection (OR 1.8).
- Osteoplastic laminotomy (laminoplasty):
- Pediatric IMSCT cohort: fusion was needed in 1/20 (5%) vs. 30% after laminectomy (adjusted OR 0.13) .
- Mixed, mostly adult intradural series of 238: no short-term difference, but shorter stays and fewer CSF leaks .
- Long-term morbidity is high even when cure is the norm: 83% of Toronto survivors had significant neurologic or orthopedic sequelae .
- Follow-up:
- serial MRI;
- standing scoliosis films;
- urology, physiatry and orthopedics through growth.
Related topics
- Spinal Ependymoma in Children: the other main intramedullary tumor.
- Diffuse Midline Glioma, H3 K27-Altered: H3 K27-altered spinal DMG.
- Pilocytic Astrocytoma: the usual low-grade histology.
- Pediatric High-Grade Glioma: pediatric-type high-grade gliomas.
- Spinal Cord Injury in Children: Classification, Management and Prognosis: spinal cord function and rehabilitation.
- Intraoperative Neuromonitoring Under Anesthesia: D-wave, MEP and SSEP monitoring during resection.
- Spinal and Spinal Cord AVMs and AV Fistulas in Children: vascular mimics of cord T2 signal.
- Syringomyelia and Hydromyelia in Children: syrinx types, causes and management.
References
- Constantini S, Miller DC, Allen JC, et al. Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg 2000;93(2 Suppl):183–193. doi:10.3171/spi.2000.93.2.0183. PMID 11012047. verified
- Scheinemann K, Bartels U, Huang A, et al. Survival and functional outcome of childhood spinal cord low-grade gliomas. J Neurosurg Pediatr 2009;4(3):254–261. doi:10.3171/2009.4.PEDS08411. PMID 19772410. verified
- Perwein T, Benesch M, Kandels D, et al. High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study group. Neuro Oncol 2021;23(7):1148–1162. doi:10.1093/neuonc/noaa296. PMID 33346834. verified
- Grob ST, Nobre L, Campbell KR, et al. Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas. Neurooncol Adv 2020;2(1):vdaa103. doi:10.1093/noajnl/vdaa103. PMID 33063010. verified
- Misove A, Vicha A, Broz P, et al. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas. Acta Neuropathol Commun 2022;10(1):143. doi:10.1186/s40478-022-01446-0. PMID 36163281. verified
- Luksik AS, Garzon-Muvdi T, Yang W, et al. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database. J Neurosurg Pediatr 2017;19(6):711–719. doi:10.3171/2017.1.PEDS16528. PMID 28362182. verified
- Azad TD, Pendharkar AV, Pan J, et al. Surgical outcomes of pediatric spinal cord astrocytomas: systematic review and meta-analysis. J Neurosurg Pediatr 2018;22(4):404–410. doi:10.3171/2018.4.PEDS17587. PMID 30028275. verified
- Jagtiani P, Karabacak M, Bahadir Z, et al. Pediatric intramedullary spinal cord tumors: a national cancer database analysis of demographics, patterns of care, and survival. Clin Neurol Neurosurg 2024;244:108457. doi:10.1016/j.clineuro.2024.108457. PMID 39042966. verified
- McGirt MJ, Goldstein IM, Chaichana KL, et al. Extent of surgical resection of malignant astrocytomas of the spinal cord: outcome analysis of 35 patients. Neurosurgery 2008;63(1):55–60. doi:10.1227/01.NEU.0000335070.37943.09. PMID 18728568. verified
- Chai RC, Yan H, An SY, et al. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma. Brain Pathol 2023;33(4):e13153. doi:10.1111/bpa.13153. PMID 36751054. verified
- Kim DH, Kim JH, Choi SH, et al. Differentiation between intramedullary spinal ependymoma and astrocytoma: comparative MRI analysis. Clin Radiol 2014;69(1):29–35. doi:10.1016/j.crad.2013.07.017. PMID 24034546. verified
- Garcia MR, Feng Y, Vasudevaraja V, et al. Clinical, pathological, and molecular characteristics of diffuse spinal cord gliomas. J Neuropathol Exp Neurol 2022;81(11):865–872. doi:10.1093/jnen/nlac075. PMID 35997552. verified
- Sala F, Palandri G, Basso E, et al. Motor evoked potential monitoring improves outcome after surgery for intramedullary spinal cord tumors: a historical control study. Neurosurgery 2006;58(6):1129–1143. doi:10.1227/01.NEU.0000215948.97195.58. PMID 16723892. verified
- Yao KC, McGirt MJ, Chaichana KL, et al. Risk factors for progressive spinal deformity following resection of intramedullary spinal cord tumors in children: an analysis of 161 consecutive cases. J Neurosurg 2007;107(6 Suppl):463–468. doi:10.3171/PED-07/12/463. PMID 18154014. verified
- Da Cunha AHGB, Guerra PLN, da Silva ICS, et al. Comparative analysis of treatment modalities for pediatric spinal cord glioblastoma: insights from a meta-analysis. Childs Nerv Syst 2025;41(1):91. doi:10.1007/s00381-024-06729-6. PMID 39812802. verified
- McGirt MJ, Chaichana KL, Atiba A, et al. Incidence of spinal deformity after resection of intramedullary spinal cord tumors in children who underwent laminectomy compared with laminoplasty. J Neurosurg Pediatr 2008;1(1):57–62. doi:10.3171/PED-08/01/057. PMID 18352804. verified
- Sergeenko OM, Gabay S, Roth J, et al. Chemotherapy for spinal cord intramedullary pediatric low-grade glioma—a systematic literature review. Pediatr Blood Cancer 2026:e70734. doi:10.1002/1545-5017.70734. PMID 42831660. verified
- Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106. PMID 34185076. verified
- McGirt MJ, Garcés-Ambrossi GL, Parker SL, et al. Short-term progressive spinal deformity following laminoplasty versus laminectomy for resection of intradural spinal tumors: analysis of 238 patients. Neurosurgery 2010;66(5):1005–1012. doi:10.1227/01.NEU.0000367721.73220.C9. PMID 20404708. verified
Verification (2026-11-16):
- Each reference's authors, title, journal, year, volume, pages, DOI and PMID were checked on PubMed.
- Every number was checked against the PubMed abstract. The WHO 2021 placement of diffuse midline glioma, H3 K27-altered, among pediatric-type diffuse high-grade gliomas, and the within-type Arabic-numeral grading, were confirmed in the open-access full text of reference 18 (PMC8328013).
- Reference 17 is an online-first 2026 article without volume or pages yet.
Caveats:
- The following are standard teaching, not drawn from the cited abstracts:
- the symptom list (gait regression, torticollis, scoliosis);
- reserving radiotherapy for refractory LGG;
- the follow-up team (urology, physiatry, orthopedics).
- References 9, 10, 12 and 19 include or mainly study adults.
- Reference 15 pools case reports and is prone to publication bias.
- The figure is an original schematic.